Abstract
Results For IFP, treatment was effective for 91 patients (73.4%), moderately effective, 3.2%, no effect, 0%, dropped out, 23.4%. For BMS, treatment was effective for 56 patients (78.9%), moderately effective, 4.2%, no effect, 1.4%, dropped out, 15.5%. Discussion Use of antidepressants can be helpful in the treatment of idiopathic orofacial pain such as IFP or BMS.
Highlights
IFP was diagnosed in 124 patients (17 men, 107 women; atypical facial pain, n=16; atypical odontalgia, n=108), with a mean age of 54.8 ±14.4 years and a mean duration of illness of 50.7 ± 62.8 months
BMS was diagnosed in 71 patients (8 men, 63 women; so-called BMS, n=28; glossodynia, n=43), with a mean age of 67.2 ± 10.8 years and a mean duration of illness of 23.1 ± 27.3 months
All participants were treated with antidepressants, with first-line therapy comprising amitriptyline or another tricyclic antidepressant (TCA)
Summary
Effectiveness of antidepressants for treatment of idiopathic orofacial pain From The European Headache and Migraine Trust International Congress London, UK. Aims To determine the efficacy of antidepressants for treating idiopathic orofacial pain fulfilling the International Classification of Headache Disorders 2nd edition (ICHD-II) criteria of persistent idiopathic facial pain (13.18.4; IFP) or burning mouth syndrome (13.18.5; BMS).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
